You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

routine surveillance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthcare-associated Infections & Antimicrobial Resistance

Recruiting
  • Antimicrobial Resistance
  • Routine Infection control
  • Gaborone, Botswana
    Princess Marina Hospital
Feb 8, 2023

(rPMS) Study of Rybelsus to Evaluate Safety and Effectiveness in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jan 27, 2023

(rPMS) Study of Ozempic to Evaluate Safety and Effectiveness in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jan 17, 2023

Advanced Immunoclinical Phenotyping of Rejection in Lung

Recruiting
  • Chronic Rejection of Lung Transplant
  • Lung transplant recipient without MRI imaging
  • Lung transplant recipient with MRI imaging
  • Charlottesville, Virginia
    University of Virginia Health System
Nov 22, 2022

(Use-results Surveillance) With Esperoct®

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa pegol
  • Fukuoka, Japan
  • +14 more
Nov 8, 2022

Routine Post-treatment Surveillance in Prostate Cancer Survivors

Completed
Has Results
  • Cancer of Prostate
  • +3 more
    • (no location specified)
    Sep 23, 2021

    Hepatitis C Trial in Seoul

    Completed
    • Hepatitis C
      • Seoul, Korea, Republic of
        Local Institution
      Jan 6, 2022

      Diarrhoea Trial in Dhaka (Hypo-osmolar ORS)

      Completed
      • Diarrhoea
      • Hypo-osmolar ORS
      • Dhaka, Bangladesh
        International Centre for Diarrhoeal Disease Research, Bangladesh
      Feb 10, 2022

      Thyroid Cancer, Thyroid, Refractory Thyroid Cancer Trial in New York (Surveillance Visit)

      Recruiting
      • Thyroid Cancer
      • +2 more
      • Surveillance Visit
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 8, 2023

      (Use Result Surveillance) With Refixia®

      Enrolling by invitation
      • Haemophilia B
      • Søborg, Denmark
      • +21 more
      Mar 13, 2022

      Esophageal Cancer Risk Registry

      Recruiting
      • Esophageal Cancer
      • +4 more
      • Survey of client health, personal habits, family history
      • +3 more
      • Pittsburgh, Pennsylvania
        Department of Cardiothoracic Surgery
      Jan 23, 2023

      (rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness

      Enrolling by invitation
      • Diabetes Mellitus, Type 2
      • Xultophy® (insulin degludec/liraglutide)
      • Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
      • +9 more
      Mar 21, 2022

      Malaria Vaccine Pilot Evaluation

      Active, not recruiting
      • Malaria,Falciparum
      • +3 more
      • Feasibility survey
      • +2 more
      • Kintampo, Ghana
      • +2 more
      Aug 6, 2021

      Venetoclax for Chronic Lymphocytic Leukemia Used in Routine

      Recruiting
      • Cancer, Chronic Lymphocytic Leukemia (CLL)
        • Seoul, Seoul Teugbyeolsi, Korea, Republic of
        • +7 more
        Mar 17, 2022

        (rPMS) Study of Ryzodeg® FlexTouch® to Evaluate Safety and

        Completed
        • Diabetes
        • +2 more
        • Insulin degludec /insulin aspart
        • Busan, Korea, Republic of
        • +26 more
        Nov 9, 2021

        Chronic Latent EBV Infection

        Recruiting
        • EBV Infection
        • peripheral EBV-DNA load
        • Wuhan, Hubei, China
          Tongji hospital, Tongji medical collage of HUST
        Feb 9, 2021

        Spinraza Injection (Nusinersen Sodium)

        Recruiting
        • Muscular Atrophy, Spinal
        • Nusinersen Sodium Injection
        • Busan, Korea, Republic of
        • +13 more
        Mar 22, 2021

        (rPMS) Study to Evaluate Safety and Effectiveness of

        Completed
        • Obesity
        • Overweight
        • Busan, Korea, Republic of
        • +27 more
        Jul 8, 2021

        Uveitis, Anterior, Juvenile Idiopathic Arthritis Trial in London (AS-OCT imaging, Slit lamp examination)

        Not yet recruiting
        • Uveitis, Anterior
        • Juvenile Idiopathic Arthritis
        • AS-OCT imaging
        • Slit lamp examination
        • London, United Kingdom
          Great Ormond Street Hospital
        Aug 2, 2023

        VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

        Not yet recruiting
        • Influenza Immunization (Healthy Volunteers)
        • Quadrivalent Influenza Vaccine
        • High-Dose Quadrivalent Influenza Vaccine
        • (no location specified)
        Sep 22, 2023

        Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)

        Recruiting
        • Squamous Cell Carcinoma
        • Standard surveillance
        • +2 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Aug 17, 2022

        Coronary Artery Disease Trial in Haifa (VIOLA proximal seal)

        Not yet recruiting
        • Coronary Artery Disease
        • VIOLA proximal seal
        • Haifa, Israel
          Rambam Health Care Campus
        Jun 12, 2023

        VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

        Completed
        • Influenza (Healthy Volunteers)
        • Quadrivalent Influenza Vaccine
        • High-Dose Quadrivalent Influenza Vaccine
        • Turku, Finland
        • +9 more
        Jan 4, 2023

        Antenatal Care asPlatform for Malaria Surveillance: Utilizing

        Completed
        • Malaria
        • ANC surveillance
        • Ouagadougou, Burkina Faso
          Centre National de Recherche et de Formation sur le Paludisme
        Dec 9, 2022

        Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))

        Active, not recruiting
        • Prostatic Neoplasms, Castration-Resistant
        • Radium-223 dichloride (Xofigo, BAY 88-8223)
        • Multiple Locations, Japan
          (unnamed)
        Feb 2, 2023